BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27530723)

  • 21. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
    Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
    Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas.
    Chai Y; Zhou Z; Song J; Lv R; Xu G; Bi J; Li X; Li Z; Huo R
    J Dermatol; 2019 Sep; 46(9):770-776. PubMed ID: 31270853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of propranolol for cutaneous hemangiomas in premature children.
    Brazzelli V; Giorgini C; Barruscotti S; Codazzi CA; Mannarino S; Tzialla C; Stronati M; Marseglia GL; Borroni G
    G Ital Dermatol Venereol; 2016 Oct; 151(5):485-91. PubMed ID: 25692776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of hepatic hemangiomas: management and outcome.
    Dickie B; Dasgupta R; Nair R; Alonso MH; Ryckman FC; Tiao GM; Adams DM; Azizkhan RG
    J Pediatr Surg; 2009 Jan; 44(1):125-33. PubMed ID: 19159729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas.
    Giachetti A; Garcia-Monaco R; Sojo M; Scacchi MF; Cernadas C; Guerchicoff Lemcke M; Dovasio F
    Pediatr Dermatol; 2014; 31(1):14-20. PubMed ID: 24283619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal Infantile Hemangioma - Presentation of 4 Cases and Review of the Selected Literature.
    Matić A; Matić M; Prćić S; Radulović A; Pajić M; Žeravica M
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):208-212. PubMed ID: 38651847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol for the treatment of subglottic hemangiomas.
    Raol N; Metry D; Edmonds J; Chandy B; Sulek M; Larrier D
    Int J Pediatr Otorhinolaryngol; 2011 Dec; 75(12):1510-4. PubMed ID: 21944056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.